stoxline Quote Chart Rank Option Currency Glossary
  
(CYTK)
  0 (0%)    09-03 15:09
Open:
High:
Volume: 0
  
Pre. Close:
Low:
Market Cap: 0(M)
Technical analysis
2026-09-03 2:43:35 PM
Short term     
Mid term     
Targets 6-month :  89.94 1-year :  95.5
Resists First :  77.01 Second :  81.76
Pivot price 75.28
Supports First :  69.3 Second :  57.66
MAs MA(5) :  71.94 MA(20) :  75.45
MA(100) :  75.57 MA(250) :  67.19
MACD MACD :  -1.6 Signal :  -1.3
%K %D K(14,3) :  27.7 D(3) :  20.2
RSI RSI(14): 42.4
52-week High :  88.3 Low :  47.22
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ CYTK ] has closed above bottom band by 32.0%. Bollinger Bands are 8.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 73.83 - 74.18 74.18 - 74.5
Low: 69.56 - 69.97 69.97 - 70.34
Close: 71.26 - 71.93 71.93 - 72.53
Company Description

Headline News

Wed, 02 Sep 2026
Can CYTK's Aficamten Strengthen Its HCM Growth Prospects? - Yahoo Finance

Tue, 01 Sep 2026
Director B Parshall Sells 5,000 Shares of Cytokinetics Inc (CYTK) - gurufocus.com

Tue, 01 Sep 2026
symbol__ Stock Quote Price and Forecast - CNN

Mon, 31 Aug 2026
What's Going On With Cytokinetics Stock Today? - Cytokinetics (NASDAQ:CYTK) - Benzinga

Mon, 31 Aug 2026
CYTK Reiterates by HC Wainwright & Co. -- Price Target Maintained at $140 - gurufocus.com

Mon, 31 Aug 2026
Cytokinetics (CYTK) Extends Aficamten Phase 3 Data, Is It Still 33% Below Fair Value? - simplywall.st

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Neutral
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Neutral
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
Sector:
Industry:
Shares Out 139 (M)
Shares Float 138 (M)
Held by Insiders 0.6 (%)
Held by Institutions 125.7 (%)
Shares Short 15,300 (K)
Shares Short P.Month 17,570 (K)
Stock Financials
EPS -7.22
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) -1.25
Profit Margin 0 %
Operating Margin -626 %
Return on Assets (ttm) -28.1 %
Return on Equity (ttm) 0 %
Qtrly Rev. Growth -57.1 %
Gross Profit (p.s.) -2.43
Sales Per Share 0.48
EBITDA (p.s.) -5.01
Qtrly Earnings Growth 0 %
Operating Cash Flow -555 (M)
Levered Free Cash Flow -397 (M)
Stock Valuations
PE Ratio -10.17
PEG Ratio 0
Price to Book value -58.71
Price to Sales 150.75
Price to Cash Flow -18.37
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android